Eli Lilly (LLY) PT Raised to $358 at BMO Capital
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $732.20 --0%
Rating Summary:
25 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 3 | New: 2
Rating Summary:
25 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 3 | New: 2
Join SI Premium – FREE
BMO Capital analyst Evan David Seigerman raised the price target on Eli Lilly (NYSE: LLY) to $358.00 (from $330.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Senate Committee Investigates Ozempic and Wegovy Costs - NYT
- Meta Platforms Inc. (META) PT Lowered to $500 at Goldman Sachs, 'Management Track Record of Execution Leaves Us Long-Term Constructive'
- BOK Financial (BOKF) PT Raised to $100 at Citi, 'limited relative upside over the near term'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
